No interactions between heparin and atacicept, an antagonist of B cell survival cytokines-Reference-Cited by-同舟云学术

No interactions between heparin and atacicept, an antagonist of B cell survival cytokines

Published:2019-10 Issue:20 Volume:176 Page:4019-4033
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:Br J Pharmacol

Author:

Kowalczyk‐Quintas Christine¹,Willen Daniela²,Willen Laure¹,Golob Michaela²,Schuepbach‐Mallepell Sonia¹,Peter Benjamin¹,Eslami Mahya¹,Vigolo Michele¹,Broly Hervé³,Samy Eileen⁴,Yalkinoglu Özkan²,Schneider Pascal¹^ORCID

Affiliation:

1. Department of BiochemistryUniversity of Lausanne Epalinges Switzerland

2. Clinical Pharmacology, Quantitative Pharmacology, Global Early DevelopmentMerck KGaA Darmstadt Germany

3. Biotech Process SciencesMerck KGaA Corsier‐sur‐Vevey Switzerland

4. EMD Serono Research & Development Institute, Inc. Billerica MA USA

Funder

Merck KGaA

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung

Publisher

Wiley

Subject

Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bph.14811

Reference36 articles.

1. THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Catalytic receptors

2. Determination of lipoprotein lipase activity using a novel fluorescent lipase assay

3. Selective activation of TACI by syndecan-2

4. Decreased affinity of recombinant antithrombin for heparin due to increased glycosylation

5. TACI, unlike BAFF-R, is solely activated by oligomeric BAFF and APRIL to support survival of activated B cells and plasmablasts

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Population pharmacokinetics of atacicept in systemic lupus erythematosus: An analysis of three clinical trials;CPT: Pharmacometrics & Systems Pharmacology;2023-06-18

2. Kinetics of free and ligand-bound atacicept in human serum;Frontiers in Immunology;2022-12-02

3. BAFFR activates PI3K/AKT signaling in human naive but not in switched memory B cells through direct interactions with B cell antigen receptors;Cell Reports;2022-06

4. Ligand-independent oligomerization of TACI is controlled by the transmembrane domain and regulates proliferation of activated B cells;Cell Reports;2022-03

5. Advanced Molecular Dynamics Approaches to Model a Tertiary Complex APRIL/TACI with Long Glycosaminoglycans;Biomolecules;2021-09-12